Maximus: Fiscal Q4 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal Q4 profit of $97M, or $1.83 per share, beating estimates. Revenue was $1.3B, also exceeding forecasts. Full-year profit was $392.6M, with revenue at $5.23B. The company expects FY earnings of $7.50-$8 per share and revenue of $5.45B-$5.65B.
How this was made

The 30-second read
Why it matters
Traders can update near-term EPS/revenue expectations based on the beat versus Zacks estimates and re-anchor valuation to the provided full-year ranges.
Market read
A company-specific earnings beat plus explicit full-year guidance typically drives estimate revisions and can move the stock if investors were positioned for a miss.
What to watch
The article does not break out segment performance, backlog, contract wins, or margin drivers, which are often what determine whether guidance is viewed as durable.
Background
Maximus is a government health services provider; this is a fiscal Q4 earnings snapshot with consensus comparisons and full-year guidance.
Ticker impact
Maximus reported fiscal Q4 profit of $97 million and adjusted EPS $2.11, beating analysts’ $1.88 estimate, plus revenue $1.3B vs $1.29B.
Likely upward bias as the market digests the EPS beat and aligns expectations to the company’s stated full-year guidance range.
The article provides a first-report earnings print with both EPS and revenue beats versus consensus, plus explicit full-year guidance ranges that can drive near-term estimate revisions.
Market effects
Reinforces demand visibility for government health services outsourcing, but no cross-company read-across is provided.
Limited, as the story is company-specific with no broader regional datapoints.
Low, since it is a US-listed single-issuer earnings/guidance update.
Counterpoint
The guidance ranges may still be the main driver, and the beat could be partially offset if investors focus on margin sustainability rather than headline EPS.
Key entities
- companyMaximus Inc.
Reported fiscal Q4 profit, adjusted EPS, revenue, and issued full-year earnings and revenue guidance.
- research_consensusZacks Investment Research
Provided the analyst consensus estimates referenced in the earnings comparison.

